Hospital Corporation of China Limited provided consolidated earnings guidance for the six months ended June 30, 2022. For the period, the Group is expected to record a loss before tax of approximately RMB 400 million to RMB 490 million (subject to further adjustments and impairment assessments) as compared with the loss before tax of approximately RMB 493 million recorded for the corresponding period in 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.4 HKD | 0.00% | 0.00% | -1.54% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-1.54% | 112M | |
-18.46% | 16.57B | |
+4.50% | 12.38B | |
+4.98% | 11.73B | |
+5.49% | 10.27B | |
+25.03% | 8.4B | |
-2.64% | 7.63B | |
+20.21% | 7.16B | |
+3.87% | 6.63B | |
+50.68% | 4.58B |
- Stock Market
- Equities
- 3869 Stock
- News Hospital Corporation of China Limited
- Hospital Corporation of China Limited Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2022